Clinical Study
Efficacy and Outcomes of Intrathecal Analgesia as Part of an Enhanced Recovery Pathway in Colon and Rectal Surgical Patients
Table 3
Comparison of opioid dosing regimens.
| | <50 mcg () | 51–75 mcg () | 76–100 mcg () | >100 mcg () | value |
| Type of intrathecal, (%) | | | | | 0.38 | IA-O | 20 (100) | 34 (94) | 388 (91) | 105 (89) | — | IA-L | 0 (0) | 2 (6) | 39 (9) | 13 (11) | — | Incidence of ileus, (%) | 5 (25) | 2 (5.6) | 70 (16) | 18 (15) | 0.24 | Length of stay (days), median (IQR) | 4 (2–5.5) | 3 (2–4.5) | 3 (2–5) | 3 (2–5) | 0.58 | Pain score, median (IQR) | | | | | | 4 hours | 2 (0.5–3) | 3 (1–4) | 3 (2–5) | 3 (1–4) | 0.30 | 8 hours | 2 (0–3) | 2 (1–3) | 2 (1–4) | 2 (1–4) | 0.76 | 16 hours | 3.5 (2–5) | 3 (2–5) | 3 (2–5) | 2 (1–5) | 0.42 | 24 hours | 3 (1–4) | 2.5 (2–4.5) | 4 (2–5) | 3 (2–6) | 0.25 | 48 hours | 2 (1–3) | 3 (2–4) | 3 (2–5) | 3 (2–6) | 0.29 | 48-hour maximum | 5 (4–7.5) | 5 (4–7) | 6 (4–7) | 6 (4–8) | 0.52 | Total OME used, median (IQR) | 7.5 (0–37.5) | 7.5 (0–48.8) | 30 (0–90) | 22.5 (0–82.5) | 0.01 |
|
|
IA: intrathecal opioid; IA-L: intrathecal opioid + local anesthetic; IQR: interquartile range.
|